Now, the fight against HIV/AIDS is not just about governments and global health organisations anymore; it is a deeply personal one. And it is all about the choices you make, the conversations you have ...

B/F/TAF shows lower ART switching rates and higher persistence among HIV patients, especially those with mental health or ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the launch of Choose U™, a new campaign that spotlights the multifaceted experiences of people living with HIV globally. The timing of the campaign ...

A vial of lenacapavir, the new HIV prevention injectable drug that only needs to be administered twice yearly but provides almost complete protection. (Nardus Engelbrecht | AP) The U.S. announced ...

PurposeMed, which was founded in early 2020, launched Freddie in Canada that July. The service – named after the late rock singer Freddie Mercury – virtually connects patients with nurses or nurse ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief ...

South Africa on Thursday welcomed a U.S. bridging plan worth $115 million that would continue funding HIV treatment and ...

Shionogi now plans to accelerate its expansion in Europe and the U.S., while pursuing full-scale growth of its new drug ...

The nation of Lesotho long had the world’s second-highest rate of HIV infections. But over years, with millions in aid from ...